Robert E. Swillo

418 total citations
15 papers, 356 citations indexed

About

Robert E. Swillo is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Hematology. According to data from OpenAlex, Robert E. Swillo has authored 15 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 5 papers in Molecular Biology and 5 papers in Hematology. Recurrent topics in Robert E. Swillo's work include Cardiac electrophysiology and arrhythmias (10 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers) and Connexins and lens biology (4 papers). Robert E. Swillo is often cited by papers focused on Cardiac electrophysiology and arrhythmias (10 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers) and Connexins and lens biology (4 papers). Robert E. Swillo collaborates with scholars based in Canada, United States and Germany. Robert E. Swillo's co-authors include James K. Hennan, David L. Crandall, John A. Butera, Stephen J. Gardell, Joel Kantrowitz, Robert G. Schaub, Eric I. Rossman, Hal S. Feldman, Ketil Haugan and Jørgen S. Petersen and has published in prestigious journals such as Circulation, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Robert E. Swillo

15 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert E. Swillo Canada 9 174 153 75 54 41 15 356
P. Htun Germany 6 69 0.4× 193 1.3× 41 0.5× 16 0.3× 43 1.0× 9 328
Manjyot K. Nanhwan United States 8 128 0.7× 163 1.1× 11 0.1× 76 1.4× 67 1.6× 9 341
C Praga Italy 9 50 0.3× 50 0.3× 91 1.2× 50 0.9× 28 0.7× 26 299
Maria Łukasik Poland 10 100 0.6× 143 0.9× 68 0.9× 25 0.5× 7 0.2× 36 324
Izabela Florek Poland 4 167 1.0× 52 0.3× 42 0.6× 62 1.1× 24 0.6× 14 346
Masashi Sada Japan 8 163 0.9× 97 0.6× 12 0.2× 48 0.9× 24 0.6× 20 320
Brooke Henderson United States 8 137 0.8× 123 0.8× 39 0.5× 65 1.2× 16 0.4× 11 361
Lloyd Michael United States 3 124 0.7× 159 1.0× 15 0.2× 71 1.3× 55 1.3× 3 349
Mélanie Hoch Germany 7 150 0.9× 212 1.4× 19 0.3× 51 0.9× 41 1.0× 7 385
Hisayoshi Fujiwara Japan 9 146 0.8× 250 1.6× 10 0.1× 24 0.4× 41 1.0× 16 439

Countries citing papers authored by Robert E. Swillo

Since Specialization
Citations

This map shows the geographic impact of Robert E. Swillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Swillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Swillo more than expected).

Fields of papers citing papers by Robert E. Swillo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert E. Swillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Swillo. The network helps show where Robert E. Swillo may publish in the future.

Co-authorship network of co-authors of Robert E. Swillo

This figure shows the co-authorship network connecting the top 25 collaborators of Robert E. Swillo. A scholar is included among the top collaborators of Robert E. Swillo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert E. Swillo. Robert E. Swillo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Rossman, Eric I., Kun Liu, Robert E. Swillo, et al.. (2009). The Gap Junction Modifier, GAP-134 [(2S,4R)-1-(2-Aminoacetyl)-4-benzamido-pyrrolidine-2-carboxylic Acid], Improves Conduction and Reduces Atrial Fibrillation/Flutter in the Canine Sterile Pericarditis Model. Journal of Pharmacology and Experimental Therapeutics. 329(3). 1127–1133. 48 indexed citations
2.
Chekler, Eugene L. Piatnitski, John A. Butera, Li Di, et al.. (2009). Discovery of a class of potent gap-junction modifiers as novel antiarrhythmic agents. Bioorganic & Medicinal Chemistry Letters. 19(16). 4551–4554. 8 indexed citations
3.
Butera, John A., Bjarne Due Larsen, James K. Hennan, et al.. (2009). Discovery of (2S,4R)-1-(2-Aminoacetyl)-4-benzamidopyrrolidine-2-carboxylic Acid Hydrochloride (GAP-134)13, an Orally Active Small Molecule Gap-Junction Modifier for the Treatment of Atrial Fibrillation. Journal of Medicinal Chemistry. 52(4). 908–911. 35 indexed citations
4.
Hennan, James K., Robert E. Swillo, Eric I. Rossman, et al.. (2009). GAP-134 ([2S,4R]-1-[2-Aminoacetyl]4-Benzamidopyrrolidine-2-Carboxylic Acid) Prevents Spontaneous Ventricular Arrhythmias and Reduces Infarct Size During Myocardial Ischemia/Reperfusion Injury in Open-Chest Dogs. Journal of Cardiovascular Pharmacology and Therapeutics. 14(3). 207–214. 20 indexed citations
5.
Hennan, James K., et al.. (2008). Effect of tiplaxtinin (PAI‐039), an orally bioavailable PAI‐1 antagonist, in a rat model of thrombosis. Journal of Thrombosis and Haemostasis. 6(9). 1558–1564. 51 indexed citations
6.
Rossman, Eric I., Kun Liu, Robert E. Swillo, et al.. (2007). Abstract 1837: Effects of the Gap Junction Modifier, GAP-134, on Conduction and Atrial Fibrillation/Flutter Inducibility in Dogs. Circulation. 116(suppl_16). 1 indexed citations
7.
Swillo, Robert E., Courtney E. Leik, Jonathan Brooks, et al.. (2006). Pharmacologic inhibition of platelet vWF-GPIbα interaction prevents coronary artery thrombosis. Thrombosis and Haemostasis. 95(3). 469–475. 35 indexed citations
8.
Hennan, James K., Robert E. Swillo, James C. Keith, et al.. (2006). Rotigaptide (ZP123) Prevents Spontaneous Ventricular Arrhythmias and Reduces Infarct Size During Myocardial Ischemia/Reperfusion Injury in Open-Chest Dogs. Journal of Pharmacology and Experimental Therapeutics. 317(1). 236–243. 71 indexed citations
9.
Hennan, James K., et al.. (2006). ID: 190 Efficacy of PAI-749, an orally active PAI-1 inhibitor, in dog and rat models of arterial and venous thrombosis. Journal of Thrombosis and Haemostasis. 4(s1). 167–167. 1 indexed citations
10.
Hennan, James K., Hassan Elokdah, Mauricio Leal, et al.. (2005). Evaluation of PAI-039 [{1-Benzyl-5-[4-(trifluoromethoxy)phenyl]-1 H-indol-3-yl}(oxo)acetic Acid], a Novel Plasminogen Activator Inhibitor-1 Inhibitor, in a Canine Model of Coronary Artery Thrombosis. Journal of Pharmacology and Experimental Therapeutics. 314(2). 710–716. 35 indexed citations
11.
Hennan, James K., Hal S. Feldman, Robert E. Swillo, et al.. (2005). ZP123 Prevents Spontaneous Ventricular Arrhythmias and Reduces Infarct Size During Myocardial Ischemia/Reperfusion Injury in Open-Chest Dogs. 4 indexed citations
12.
Crandall, David L., et al.. (2003). WAY-140312 reduces plasma PAI-1 while maintaining normal platelet aggregation. Biochemical and Biophysical Research Communications. 311(4). 904–908. 10 indexed citations
13.
Friedrichs, Gregory S., et al.. (2002). Sphingosine Modulates Myocyte Electrophysiology, Induces Negative Inotropy, and Decreases Survival After Myocardial Ischemia. Journal of Cardiovascular Pharmacology. 39(1). 18–28. 29 indexed citations
14.
Gomoll, Allen W., et al.. (1997). Effect of Timing of Treatment of the Glyburide-Reversible Cardioprotective Activity of BMS-180448. Journal of Pharmacology and Experimental Therapeutics. 281(1). 24–33. 7 indexed citations
15.
Grebow, Peter E., William P. Feeney, John Lettieri, et al.. (1981). The pharmacodynamics of bucainide (RHC G233): pharmacokinetic parameters and relationship between plasma levels and the effect on the electrocardiogram in the dog.. PubMed. 32(3). 407–21. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. Htun Breakdown of academic impact, for papers by Manjyot K. Nanhwan Breakdown of academic impact, for papers by C Praga Breakdown of academic impact, for papers by Maria Łukasik Breakdown of academic impact, for papers by Izabela Florek Breakdown of academic impact, for papers by Masashi Sada Breakdown of academic impact, for papers by Brooke Henderson Breakdown of academic impact, for papers by Lloyd Michael Breakdown of academic impact, for papers by Mélanie Hoch Breakdown of academic impact, for papers by Hisayoshi Fujiwara
Rankless by CCL
2026